Clinical characteristics of relapsed ovarian cancer patients with striking response to the bevacizumab at first relapse

Simple item page
dc.contributor.authorKose, Fatih
dc.contributor.authorAlemdaroglu, S.
dc.contributor.authorMertsoylu, H.
dc.contributor.authorBesen, A.
dc.contributor.authorGuler, O.
dc.contributor.authorSimsek, S.
dc.contributor.authorErbay, G.
dc.contributor.authorOnal, C.
dc.contributor.authorCelik, H.
dc.date.accessioned2020-11-02T16:05:22Z
dc.date.available2020-11-02T16:05:22Z
dc.date.issued2019
dc.description.sponsorship10th Eurasian Hematology Oncology Congressen_US
dc.identifier.endpageS34en_US
dc.identifier.issn0145-2126en_US
dc.identifier.startpageS34en_US
dc.identifier.urihttp://hdl.handle.net/11727/4989
dc.identifier.volume85en_US
dc.identifier.wos000489290100040en_US
dc.language.isoengen_US
dc.relation.journalLEUKEMIA RESEARCHen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleClinical characteristics of relapsed ovarian cancer patients with striking response to the bevacizumab at first relapseen_US
dc.typeconferenceObjecten_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Tıp Fakültesi / Faculty of Medicine
Wos İndeksli Yayınlar Koleksiyonu
Wos Kapalı Erişimli Yayınlar